North America Cancer Therapy Market Size To Worth USD 6.95 Billion By 2033 | CAGR of 8.3%
Category: HealthcareNorth America Cancer Therapy Market Size To Worth USD 6.95 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the North America Cancer Therapy Market Size is to Grow from USD 3.13 Billion in 2023 to USD 6.95 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 8.3% during the projected period.
Get more details on this report -
Browse key industry insights spread across 164 pages with 110 Market data tables and figures & charts from the report on the "North America Cancer Therapy Market Size, Share, and COVID-19 Impact Analysis, By Therapy Type (Chemotherapy, Radiation Therapy, Hormonal Therapy, Targeted Therapy, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancer, and Others), and North America Cancer Therapy Market Insights, Industry Trend, Forecasts to 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/north-america-cancer-therapy-market
Cancer therapy is a term that encompasses many therapies and strategies aimed at treating cancer and preventing its spread. Cancer treatment is directed to kill cancer cells, inhibit their growth, or relieve the symptoms of the disease. Factors that determine the kind of cancer therapy are the type and stage of the cancer, a patient's overall health, and the properties of the cancer cells. The North America cancer therapy market is experiencing a rapid growth rate, primarily due to the increasing evidence of cancer on a large scale, which informs people and increases the growing demand for therapies to treat the condition. Furthermore, the growing need for cancer treatment thus directly fuels market growth. Some various cancers and subspecies require a large number of treatment options. Cancer is increasingly becoming bulky in its types, thereby creating a requirement for developing new therapies, which, in turn, creates an environment of innovation and fuels market growth. Personalized medicine is increasingly gaining acceptance as more is learned about cancer at the molecular and genetic levels. However, therefore, the lack of critical medicines against cancer can create challenges in accessing the needed treatments for many patients. It can mean that particular treatments cannot be reached by certain patients located in specific geographical areas or with specific types of cancer.
The chemotherapy segment is anticipated to hold the greatest share of the North America cancer therapy market during the projected timeframe.
Based on the technology, the North America cancer therapy market is divided into chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and others. Among these, the chemotherapy segment is anticipated to hold the greatest share of the North America cancer therapy market during the projected timeframe. This is attributed to the chemotherapy drugs used in adjuvant therapy, after primary treatments such as surgery or radiation. These remaining cancer cells are destroyed and the chances of a return of cancer are reduced. Leukemia, lymphoma, breast cancer, and lung cancer are among the majority of the cancers that it is used to treat. Its wide application makes it an integral part of the treatment aspect of cancers.
The breast cancer segment is anticipated to hold the greatest share of the North America cancer therapy market during the projected timeframe.
Based on the cancer type, the North America cancer therapy market is divided into breast cancer, lung cancer, prostate cancer, blood cancer, and others. Among these, the breast cancer segment is anticipated to hold the greatest share of the North America cancer therapy market during the projected timeframe. This is attributed to the treatment for breast cancer can range from surgery alone to chemotherapy and/or radiation therapy, hormone therapy, and/or targeted therapy or immunotherapy. The choice of treatment also depends on the stage of the disease, receptor status of hormones, HER2 status, and overall health of the patient.
Major vendors in the North America cancer therapy Market include Johnson and Johnson, AstraZeneca PLC, Merck & Co. Inc., Bayer AG, Amgen Inc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Novartis AG, Pfizer Inc, Bristol Myers Squibb Company, and Others.
Recent Developments
- In September 2022, Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Retevmo (selpercatinib, 40 mg, and 80 mg capsules) for adult patients with locally advanced or metastatic solid tumors with a rearranged during transfection (RET) gene fusion that has progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at North America, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the North America cancer therapy Market based on the below-mentioned segments:
North America Cancer Therapy Market, By Therapy Type
- Chemotherapy
- Radiation Therapy
- Hormonal Therapy
- Targeted Therapy
- Others
North America Cancer Therapy Market, By Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Blood Cancer
- Others
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?